𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Cost analysis of plasma-exchange therapy for the treatment of Guillain-Barré syndrome

✍ Scribed by H. Espérou; M.-C. Jars-Guincestre; F. Bolgert; J.-C. Raphaël; I. Durand-Zaleski; and the French Cooperative Group ¶on Plasma Exchange ¶in Guillain-Barré Syndrome

Publisher
Springer
Year
2000
Tongue
English
Weight
97 KB
Volume
26
Category
Article
ISSN
1432-1238

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment of Guillain-Barré syndrome by
Treatment of Guillain-Barré syndrome by plasma exchange
✍ E. Rumpl; U. Mayr; F. Gerstenbrand; J. M. Hackl; P. Rosmanith; F. Aichner 📂 Article 📅 1981 🏛 Springer 🌐 English ⚖ 931 KB

Plasma exchange has been used for therapy in eight patients with the Guillain-Barré syndrome. All patients were severely ill. They became tetraplegic and showed cranial nerve involvement. Five patients received assisted respiration, but the others were also at risk of ventilatory insufficiency. Reco

Treatment of Guillain-Barré syndrome: A
Treatment of Guillain-Barré syndrome: A cost-effectiveness analysis
✍ Seema Nagpal; Tim Benstead; Kenneth Shumak; Gail Rock; Murray Brown; David R. An 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB 👁 1 views

Acute Guillain-Barre ´syndrome is the most common cause of neuromuscular paralysis. Plasma exchange and intravenous immune globulin (IV IgG) are both effective treatments for this condition and the purpose of this report was to compare the cost-effectiveness of these two modalities. A MEDLINE search

The acute phase reactant, fibrinogen, as
The acute phase reactant, fibrinogen, as a guide to plasma exchange therapy for acute Guillain-Barré syndrome
✍ Rashmi Sanjay; Janice Flanagan; Donata Sodano; Kenneth C. Gorson; Allan H. Roppe 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 121 KB

The Guillian Barré syndrome is an acute inflammatory disorder for which plasma exchange is effective treatment. Up to 10% relapse after plasma exchange suggesting that treatment sometimes finishes before disease activity has resolved. We studied whether plasma fibrinogen, an inflammatory marker, mig